Allergan And Editas Sharpen Their CRISPR Focus On Ocular Drugs

 
• By Sten Stovall
SC1808_Genome Editing_1146082469_1200.jpg
Duo to jointly develop and market EDIT-101 For LCA10 • Source: Shutterstock

More from Business

More from Scrip